Aadi Bioscience Stock Investor Sentiment

AADI Stock  USD 2.22  0.08  3.48%   
Under 68% of Aadi Bioscience's investor base is looking to short. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that many traders are alarmed. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
  

Aadi Bioscience Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aadi Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at news.google.com         
BML Capital Management LLC Takes 4.12 Million Position in Aadi Bioscience, Inc. - MarketBeat
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Aadi Bioscience Posts Quarterly Earnings Results, Meets Expectations
news
over two weeks ago at finance.yahoo.com         
Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
Yahoo News
over two weeks ago at gurufocus.com         
Aadi Bioscience Inc Q3 2024 Earnings Revenue Hits 7. ...
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
Aadi Bioscience, Inc. Reports Q3 Loss, Tops Revenue Estimates
zacks News
over two weeks ago at thelincolnianonline.com         
Aadi Bioscience Scheduled to Post Earnings on Wednesday
news
over three weeks ago at news.google.com         
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update - Morningstar
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Dalal Anupam of 18573 shares of Aadi Bioscience at 13.46 subject to Rule 16b-3
Macroaxis News
over a month ago at investing.com         
Disposition of 9689 shares by David Lennon of Aadi Bioscience at 1.94 subject to Rule 16b-3
Investing News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 32558 shares by David Lennon of Aadi Bioscience subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 9583 shares by Neil Desai of Aadi Bioscience at 7.446 subject to Rule 16b-3
Macroaxis News
over two months ago at news.google.com         
Aadi Bioscience Launches Executive Retention Bonus Program - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Aadi Bioscience executive chairman sells shares worth over 68,000 - Investing.com
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Disposition of 9583 shares by Neil Desai of Aadi Bioscience at 7.446 subject to Rule 16b-3
Macroaxis News
over two months ago at www.macroaxis.com         
Disposition of 40000 shares by Neil Desai of Aadi Bioscience at 1.7079 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Aadi Bioscience that are available to investors today. That information is available publicly through Aadi media outlets and privately through word of mouth or via Aadi internal channels. However, regardless of the origin, that massive amount of Aadi data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aadi Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aadi Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aadi Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aadi Bioscience alpha.

Aadi Bioscience Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 40000 shares by Neil Desai of Aadi Bioscience at 1.7079 subject to Rule 16b-3
09/03/2024
2
Disposition of 9583 shares by Neil Desai of Aadi Bioscience at 7.446 subject to Rule 16b-3
09/05/2024
3
Aadi Bioscience executive chairman sells shares worth over 68,000 - Investing.com
09/06/2024
4
Disposition of 32558 shares by David Lennon of Aadi Bioscience subject to Rule 16b-3
10/02/2024
5
Acquisition by Dalal Anupam of 18573 shares of Aadi Bioscience at 13.46 subject to Rule 16b-3
10/04/2024
6
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update - Morningstar
10/30/2024
7
Aadi Bioscience Inc Q3 2024 Earnings Revenue Hits 7. ...
11/06/2024
8
BML Capital Management LLC Takes 4.12 Million Position in Aadi Bioscience, Inc. - MarketBeat
11/12/2024

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences